Source: Reuters
06.27.2007
GlaxoSmithKline Plc's experimental vaccine Cervarix has proved more than 90 percent effective in preventing precancerous lesions due to two types of a virus responsible for most cases of cervical cancer.
External Link: http://www.reuters.com/article/healthNews/idUSL2687568520070...
News, Press & Media Mentions